![]() |
||||||
|
![]() | |
![]() | |
![]() | Expression of this gene in the resistant group across all datasets and cell types |
![]() | Significant ligand-receptor pairs related to this gene (This gene does not contain this module) |
![]() | Known drug resistance mechanisms of this gene (This gene does not contain this module) |
![]() | |
![]() | |
![]() | Acts as a transcription factor (This gene does not contain this module) |
![]() | Acts as a drug target< (This gene does not contain this module) |
Gene: MAD2L1BP |
Summary for MAD2L1BP |
Gene information | Gene symbol | MAD2L1BP | Ensembl ID | ENSG00000124688 |
Entrez ID | 9587 | |
Gene name | MAD2L1 binding protein | |
Synonyms | CMT2|dJ261G23.1|KIAA0110 | |
Gene type | protein_coding | |
UniProtAcc | Q15013 |
Top |
Dataset with differentially expressed gene: MAD2L1BP |
![]() |
Dataset | Source | Tissue | Cancer type level1 | Cancer type level2 | Drug type | Regimen | Timepoint | Cell type | avg_log2FC | p_val_adj |
GSE186960 | Panc1 cell line | Cell line | Pancreatic cancer | Pancreatic ductal adenocarcinoma (PDAC) | Chemotherapy | gemcitabine | NA | Malignant cells | -0.520591 | 0.00e+00 |
GSE161801_PI | patients | Bone marrow aspirate | Multiple myeloma | Refractory multiple myeloma (MM) | Targeted therapy | carfilzomib + dexamethasone | pre | B cells | -0.393664 | 4.41e-05 |
GSE175716 | PDX | Tumor tissue | Liver cancer | Advanced hepatocellular carcinoma | Targeted therapy | sorafenib | NA | Malignant cells | -0.320558 | 8.46e-29 |
Top |
Expression of MAD2L1BP in the resistant group across all datasets and cell types |
![]() |
![]() |
Top |
Significant ligand-receptor pairs related to MAD2L1BP |
![]() |
Top |
Known drug resistance mechanisms of this gene |
![]() |
Top |
MicroRNAs (miRNA) regulating MAD2L1BP |
![]() |
Gene symbol | miRNA | Score | GeneBank accession |
MAD2L1BP | hsa-miR-3157-5p | 96.3124 | NM_014628 |
MAD2L1BP | hsa-miR-651-5p | 90.6678 | NM_014628 |
MAD2L1BP | hsa-miR-3159 | 83.2273 | NM_014628 |
Page: 1 |
Top |
Motifs and transcription factors (TFs) regulating MAD2L1BP |
![]() |
Gene symbol | motif | TF_highConf |
MAD2L1BP | metacluster_107.2 | CERS2; CERS3; CERS4; CERS5; CERS6 (inferredBy_Orthology). |
MAD2L1BP | metacluster_119.2 | CCNT2; GATA1; GATA1; GATA1; GATA1; GATA2; GATA2; GATA2; NCOA1; TAL1; TAL1; TAL1; TAL1; ZNF823 (directAnnotation). GATA1; TAL1; TAL1; TAL1; TAL1 (inferredBy_Orthology). |
MAD2L1BP | metacluster_168.18 | ZNF214; ZNF239; ZNF45; ZNF696 (directAnnotation). |
MAD2L1BP | jaspar__MA0185.1 | DEAF1 (inferredBy_Orthology). |
MAD2L1BP | metacluster_191.2 | ELK4; NR2C2; NR2C2; NR2C2; NR2C2 (directAnnotation). GABPA (inferredBy_Orthology). |
MAD2L1BP | metacluster_191.3 | EHF; ELF1; ELF1; ELF1; ELF4; ELK1; ELK3; ELK3; ELK4; ELK4; ERF; ETS1; ETS2; ETV3; ETV4; ETV5; FEV; FEV; FLI1; FLI1; GABPA; GABPA; GABPA; GABPA; GABPA; GABPA; SPDEF; ZNF200 (directAnnotation). ELK1; ELK1; ELK3; ELK3; ELK4; ELK4; ETV1; ETV1; ETV4; ETV4; ETV4; ETV5; GABPA; GABPA (inferredBy_Orthology). |
MAD2L1BP | taipale_tf_pairs__ETS2_RCCGGAAGTG_HT | ETS2 (directAnnotation). |
MAD2L1BP | metacluster_166.4 | BCLAF1; EHF; ELF1; ELF1; ELF1; ELF1; ELF1; ELF1; ELF2; ELF2; ELF4; ELK1; ELK1; ELK1; ELK1; ELK1; ELK1; ELK1; ELK1; ELK1; ELK3; ELK3; ELK3; ELK3; ELK4; ERG; ERG; ERG; ERG; ETS1; ETS1; ETS1; ETS1; ETS1; ETV1; ETV1; ETV1; ETV1; ETV2; ETV3; ETV4; ETV4; ETV4; ETV4; ETV4; ETV5; ETV7; FEV; FEV; FLI1; FLI1; FLI1; FLI1; GABPA; GABPA; GABPA; GABPA; GABPA; GABPA; GABPB1; GATAD1; PHF20; ZBTB25; ZBTB40 (directAnnotation). EHF; ELF1; ELF1; ELF3; ELF5; ELK3; ELK4; ERG; ETS1; ETV1; ETV2; ETV4; FLI1; GABPA; GABPA (inferredBy_Orthology). |
MAD2L1BP | taipale_tf_pairs__FOXO1_ELK3_RCCGGAWGTKKW_CAP | ELK3; FOXO1 (directAnnotation). |
MAD2L1BP | taipale_tf_pairs__ELF2_NATGCGGAAGTR_HT | ELF2 (directAnnotation). |
MAD2L1BP | metacluster_33.8 | BRCA1; CHD2; CHD2; ETS1; NR3C1; ZBED1; ZBED1; ZBED1; ZBTB33; ZBTB33; ZBTB33; ZBTB33; ZBTB33; ZBTB33; ZBTB33 (directAnnotation). CHD2; ZBTB33 (inferredBy_Orthology). |
MAD2L1BP | taipale_tf_pairs__ETV5_FOXI1_RSCGGATGTTGN_CAP | ETV5; FOXI1 (directAnnotation). |
Page: 1 |
Top |
Acts as a transcription factor |
![]() |
Top |
Acts as a drug target |
![]() |
1 | "Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618." |
2 | "Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335." |